Search

everythinglearnresearchcommunity

for

Search:↓

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Most dogs with adrenal-dependent hypercortisolism had normal blood pressure after one year of treatment or surgery.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Testosterone raises blood pressure and changes kidney protein levels.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

MR antagonists may improve skin health and wound healing, especially in aging.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Overexpression of a specific receptor in mice skin causes skin thinning, early skin barrier formation, eye issues, and hair loss.

Hair analysis can help diagnose adrenal disorders non-invasively.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Adrenal disorders can cause lasting brain and behavior issues in children.

Balding in men is strongly linked to high blood pressure and family history.